 Rashikh Choudhury
Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 11 | 2025 | 277 | 4.350 |
Why?
| | Kidney Transplantation | 9 | 2025 | 680 | 3.050 |
Why?
| | Liver Transplantation | 19 | 2025 | 768 | 2.870 |
Why?
| | Gastrectomy | 8 | 2025 | 132 | 2.430 |
Why?
| | Gastric Bypass | 6 | 2023 | 119 | 2.290 |
Why?
| | Kidney Failure, Chronic | 5 | 2025 | 599 | 1.930 |
Why?
| | Decision Support Techniques | 11 | 2025 | 433 | 1.920 |
Why?
| | Tissue and Organ Procurement | 6 | 2022 | 319 | 1.440 |
Why?
| | Death | 3 | 2022 | 124 | 1.200 |
Why?
| | Bariatric Surgery | 4 | 2025 | 220 | 1.180 |
Why?
| | Tissue Donors | 4 | 2022 | 406 | 1.150 |
Why?
| | Health Services Accessibility | 3 | 2025 | 1030 | 1.120 |
Why?
| | Markov Chains | 6 | 2025 | 123 | 1.080 |
Why?
| | Weight Loss | 8 | 2025 | 794 | 0.950 |
Why?
| | Renal Veins | 1 | 2025 | 17 | 0.940 |
Why?
| | Renal Nutcracker Syndrome | 1 | 2025 | 8 | 0.930 |
Why?
| | Receptors, Gastrointestinal Hormone | 1 | 2025 | 7 | 0.920 |
Why?
| | Tissue Plasminogen Activator | 3 | 2020 | 239 | 0.830 |
Why?
| | Living Donors | 5 | 2022 | 269 | 0.820 |
Why?
| | Digestive System Surgical Procedures | 2 | 2020 | 109 | 0.700 |
Why?
| | Graft Survival | 8 | 2022 | 502 | 0.690 |
Why?
| | Stents | 1 | 2025 | 535 | 0.690 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2024 | 263 | 0.670 |
Why?
| | Short Bowel Syndrome | 1 | 2020 | 27 | 0.640 |
Why?
| | Organ Transplantation | 2 | 2021 | 252 | 0.610 |
Why?
| | Salvage Therapy | 1 | 2020 | 154 | 0.600 |
Why?
| | Obesity | 7 | 2025 | 3007 | 0.590 |
Why?
| | Body Mass Index | 5 | 2025 | 2390 | 0.510 |
Why?
| | Heart Transplantation | 2 | 2023 | 714 | 0.450 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 374 | 0.450 |
Why?
| | Coronavirus Infections | 1 | 2020 | 370 | 0.440 |
Why?
| | Life Expectancy | 1 | 2014 | 71 | 0.420 |
Why?
| | Waiting Lists | 5 | 2022 | 245 | 0.380 |
Why?
| | Humans | 42 | 2025 | 141284 | 0.370 |
Why?
| | Heart Failure | 2 | 2023 | 2096 | 0.340 |
Why?
| | Middle Aged | 21 | 2025 | 34658 | 0.330 |
Why?
| | Treatment Outcome | 10 | 2024 | 11216 | 0.330 |
Why?
| | Donor Selection | 2 | 2021 | 77 | 0.320 |
Why?
| | Survival Rate | 6 | 2023 | 1979 | 0.310 |
Why?
| | Blood Coagulation Disorders | 2 | 2022 | 190 | 0.300 |
Why?
| | Exercise Therapy | 1 | 2013 | 453 | 0.290 |
Why?
| | United States | 11 | 2023 | 15298 | 0.280 |
Why?
| | End Stage Liver Disease | 3 | 2023 | 76 | 0.250 |
Why?
| | Thrombelastography | 3 | 2022 | 175 | 0.230 |
Why?
| | Organ Preservation | 1 | 2025 | 111 | 0.220 |
Why?
| | Transplantation, Autologous | 1 | 2025 | 282 | 0.210 |
Why?
| | Perfusion | 1 | 2025 | 226 | 0.210 |
Why?
| | Retrospective Studies | 14 | 2023 | 16447 | 0.210 |
Why?
| | Mesothelioma | 1 | 2022 | 46 | 0.190 |
Why?
| | Male | 18 | 2025 | 70140 | 0.190 |
Why?
| | Blood Coagulation | 2 | 2022 | 268 | 0.180 |
Why?
| | Peritoneal Neoplasms | 1 | 2022 | 102 | 0.180 |
Why?
| | Hyperthermia, Induced | 1 | 2022 | 120 | 0.180 |
Why?
| | Female | 18 | 2025 | 75814 | 0.180 |
Why?
| | Parents | 2 | 2020 | 1439 | 0.170 |
Why?
| | Fibrinolysis | 2 | 2020 | 162 | 0.170 |
Why?
| | Pilonidal Sinus | 1 | 2020 | 3 | 0.170 |
Why?
| | Comprehension | 1 | 2022 | 182 | 0.170 |
Why?
| | Reperfusion | 1 | 2020 | 44 | 0.160 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2020 | 41 | 0.160 |
Why?
| | Biliary Atresia | 1 | 2022 | 153 | 0.160 |
Why?
| | Hemostatic Techniques | 1 | 2020 | 52 | 0.160 |
Why?
| | Hepatitis C, Chronic | 1 | 2022 | 146 | 0.160 |
Why?
| | Blood Component Transfusion | 1 | 2020 | 98 | 0.160 |
Why?
| | Clinical Decision-Making | 2 | 2020 | 341 | 0.150 |
Why?
| | Hepatitis C | 1 | 2022 | 250 | 0.150 |
Why?
| | Postoperative Period | 2 | 2020 | 359 | 0.140 |
Why?
| | Resuscitation | 1 | 2020 | 295 | 0.130 |
Why?
| | Wound Healing | 1 | 2020 | 349 | 0.130 |
Why?
| | Matched-Pair Analysis | 1 | 2017 | 38 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 277 | 0.130 |
Why?
| | Drug Overdose | 1 | 2021 | 359 | 0.130 |
Why?
| | Postoperative Complications | 3 | 2020 | 2831 | 0.130 |
Why?
| | Heart-Assist Devices | 1 | 2022 | 561 | 0.130 |
Why?
| | Graft Rejection | 1 | 2020 | 545 | 0.130 |
Why?
| | Allografts | 1 | 2017 | 148 | 0.120 |
Why?
| | Adult | 13 | 2024 | 39319 | 0.120 |
Why?
| | Kidney | 2 | 2022 | 1482 | 0.120 |
Why?
| | Multivariate Analysis | 2 | 2017 | 1505 | 0.120 |
Why?
| | Chi-Square Distribution | 1 | 2017 | 526 | 0.120 |
Why?
| | Hand-Assisted Laparoscopy | 1 | 2015 | 4 | 0.120 |
Why?
| | Databases, Factual | 2 | 2021 | 1449 | 0.110 |
Why?
| | Time Factors | 4 | 2021 | 6951 | 0.110 |
Why?
| | Pandemics | 2 | 2021 | 1655 | 0.110 |
Why?
| | Peritoneal Cavity | 1 | 2014 | 30 | 0.110 |
Why?
| | Chemotherapy, Cancer, Regional Perfusion | 1 | 2014 | 29 | 0.110 |
Why?
| | Infant, Newborn | 3 | 2021 | 6270 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 1 | 2017 | 910 | 0.110 |
Why?
| | Registries | 2 | 2020 | 2205 | 0.110 |
Why?
| | Follow-Up Studies | 4 | 2020 | 5222 | 0.110 |
Why?
| | Risk Factors | 5 | 2024 | 10490 | 0.110 |
Why?
| | Prognosis | 3 | 2024 | 4080 | 0.100 |
Why?
| | Critical Illness | 1 | 2020 | 852 | 0.100 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1268 | 0.100 |
Why?
| | Gastroplasty | 1 | 2013 | 32 | 0.100 |
Why?
| | Morbidity | 1 | 2014 | 320 | 0.100 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 568 | 0.100 |
Why?
| | Diet Therapy | 1 | 2013 | 37 | 0.100 |
Why?
| | Robotic Surgical Procedures | 1 | 2015 | 151 | 0.100 |
Why?
| | Microbiota | 1 | 2020 | 753 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 716 | 0.100 |
Why?
| | Weight Reduction Programs | 1 | 2013 | 117 | 0.090 |
Why?
| | Knee Prosthesis | 1 | 2012 | 26 | 0.090 |
Why?
| | Healthcare Disparities | 1 | 2018 | 674 | 0.090 |
Why?
| | Prosthesis-Related Infections | 1 | 2012 | 98 | 0.090 |
Why?
| | Liver Cirrhosis | 1 | 2013 | 283 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 1791 | 0.080 |
Why?
| | Young Adult | 4 | 2023 | 13727 | 0.080 |
Why?
| | Endocrine System | 1 | 2009 | 21 | 0.080 |
Why?
| | Adipogenesis | 1 | 2009 | 56 | 0.080 |
Why?
| | Transplant Recipients | 2 | 2022 | 181 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1336 | 0.070 |
Why?
| | Receptors, Glucocorticoid | 1 | 2009 | 137 | 0.070 |
Why?
| | Adipocytes | 1 | 2009 | 220 | 0.070 |
Why?
| | Propensity Score | 2 | 2023 | 337 | 0.070 |
Why?
| | Self Report | 1 | 2012 | 859 | 0.070 |
Why?
| | Child | 6 | 2022 | 22390 | 0.070 |
Why?
| | Motor Activity | 1 | 2012 | 717 | 0.070 |
Why?
| | Aged | 7 | 2023 | 24836 | 0.060 |
Why?
| | Colorectal Neoplasms | 1 | 2014 | 811 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2022 | 1243 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2020 | 2069 | 0.060 |
Why?
| | Prospective Studies | 3 | 2020 | 7805 | 0.050 |
Why?
| | Liver | 2 | 2022 | 1821 | 0.050 |
Why?
| | Delayed Graft Function | 1 | 2022 | 33 | 0.050 |
Why?
| | Brain Death | 1 | 2022 | 51 | 0.050 |
Why?
| | Risk Assessment | 2 | 2022 | 3522 | 0.050 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2022 | 65 | 0.050 |
Why?
| | Portoenterostomy, Hepatic | 1 | 2022 | 42 | 0.050 |
Why?
| | Ventricular Remodeling | 1 | 2023 | 258 | 0.040 |
Why?
| | Benchmarking | 1 | 2022 | 179 | 0.040 |
Why?
| | Incidence | 2 | 2020 | 2809 | 0.040 |
Why?
| | Austria | 1 | 2020 | 8 | 0.040 |
Why?
| | Surgeons | 1 | 2025 | 335 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2020 | 68 | 0.040 |
Why?
| | Switzerland | 1 | 2020 | 38 | 0.040 |
Why?
| | Computer Systems | 1 | 2020 | 52 | 0.040 |
Why?
| | Viscosity | 1 | 2020 | 92 | 0.040 |
Why?
| | Liver Function Tests | 1 | 2020 | 106 | 0.040 |
Why?
| | Hepacivirus | 1 | 2022 | 239 | 0.040 |
Why?
| | Kidney Function Tests | 1 | 2020 | 159 | 0.040 |
Why?
| | Cause of Death | 1 | 2021 | 449 | 0.040 |
Why?
| | Surgical Flaps | 1 | 2020 | 144 | 0.040 |
Why?
| | Transplantation, Homologous | 1 | 2020 | 411 | 0.040 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2019 | 89 | 0.040 |
Why?
| | Preoperative Period | 1 | 2019 | 143 | 0.040 |
Why?
| | Sex Factors | 1 | 2024 | 2055 | 0.030 |
Why?
| | Cohort Studies | 2 | 2021 | 5809 | 0.030 |
Why?
| | Eligibility Determination | 1 | 2018 | 69 | 0.030 |
Why?
| | Infant | 2 | 2022 | 9820 | 0.030 |
Why?
| | Fetus | 1 | 2020 | 797 | 0.030 |
Why?
| | Child, Preschool | 2 | 2021 | 11511 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2023 | 3577 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 748 | 0.030 |
Why?
| | Blood Transfusion | 1 | 2019 | 395 | 0.030 |
Why?
| | Operative Time | 1 | 2015 | 158 | 0.030 |
Why?
| | Education, Medical, Continuing | 1 | 2015 | 128 | 0.030 |
Why?
| | Age Factors | 1 | 2021 | 3295 | 0.030 |
Why?
| | Metabolomics | 1 | 2019 | 702 | 0.020 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2014 | 383 | 0.020 |
Why?
| | Remission Induction | 1 | 2012 | 306 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2014 | 7948 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2014 | 1397 | 0.020 |
Why?
| | Survival Analysis | 1 | 2013 | 1322 | 0.020 |
Why?
| | Estrogens, Non-Steroidal | 1 | 2009 | 10 | 0.020 |
Why?
| | Endrin | 1 | 2009 | 13 | 0.020 |
Why?
| | 3T3-L1 Cells | 1 | 2009 | 36 | 0.020 |
Why?
| | Luciferases | 1 | 2009 | 148 | 0.020 |
Why?
| | Patient Selection | 1 | 2013 | 685 | 0.020 |
Why?
| | Reoperation | 1 | 2012 | 599 | 0.020 |
Why?
| | Phthalic Acids | 1 | 2009 | 52 | 0.020 |
Why?
| | Benzhydryl Compounds | 1 | 2009 | 76 | 0.020 |
Why?
| | Models, Statistical | 1 | 2013 | 669 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2009 | 270 | 0.020 |
Why?
| | Phenols | 1 | 2009 | 111 | 0.020 |
Why?
| | Prednisone | 1 | 2009 | 228 | 0.020 |
Why?
| | Length of Stay | 1 | 2014 | 1265 | 0.020 |
Why?
| | Environment | 1 | 2009 | 342 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 244 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 5948 | 0.020 |
Why?
| | Genetic Testing | 1 | 2009 | 462 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2009 | 607 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2009 | 522 | 0.020 |
Why?
| | Diet | 1 | 2013 | 1277 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2009 | 534 | 0.010 |
Why?
| | Stem Cells | 1 | 2009 | 604 | 0.010 |
Why?
| | Adolescent | 1 | 2023 | 22116 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2009 | 1983 | 0.010 |
Why?
| | Exercise | 1 | 2013 | 2113 | 0.010 |
Why?
| | Mice | 1 | 2009 | 17969 | 0.010 |
Why?
| | Animals | 1 | 2009 | 37328 | 0.000 |
Why?
|
|
Choudhury's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|